IONIS PHARMACEUTICALS INC (IONS) has 24 SEC Form 4 insider filings on record in the last 90 days. That includes 1 insider purchase totalling $1.1M, and 4 sales totalling $2.9M. Most recent filing: Sept. 2, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 2, 2026 filed Aug. 31, 2026 | BENNETT C FRANK EVP, Chief Scientific Officer | $5,644 | 110 | +0% | No | |
|
|
||||||
| Sept. 2, 2026 filed Aug. 31, 2026 | Birchler Brian EVP, Corp and Development Ops | $2,976 | 58 | +0% | No | |
|
|
||||||
| Sept. 2, 2026 filed Aug. 31, 2026 | Monia Brett P Chief Executive Officer | $5,028 | 98 | +0% | No | |
|
|
||||||
| Sept. 2, 2026 filed Aug. 31, 2026 | O'NEIL PATRICK R. EVP CLO & General Counsel | $3,232 | 63 | +0% | No | |
|
|
||||||
| July 31, 2026 filed July 30, 2026 | Hayden Michael R Director | +$1,058,700 | 20,000 | +500% | No | |
|
|
||||||
Showing the 5 most recent of 24 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free